Prognostic impact of histopathological features and serum inflammatory markers in patients with gastric cancer undergoing neoadjuvant therapy
Current neoadjuvant therapies prolong disease-free and OS. The practical application of serum inflammatory markers (NLR and PLR) is limited due to the lack of standard cut-off values. Nutritional status, hypoalbuminemia, and incomplete perioperative chemotherapy have been associated with poor prognosis.
Authors
- Tahir Kemal Şahin (ORCID: https://orcid.org/0000-0002-4836-1759)
- Özgecan Dülgar (ORCID: https://orcid.org/0000-0002-0678-4024)
- Murat Yakın (ORCID: https://orcid.org/0000-0002-5084-2033)
- Ayberk Bayramgil (ORCID: https://orcid.org/0000-0003-1782-7808)
- Tanju Kapağan (ORCID: https://orcid.org/0000-0001-9381-1934)
- Varlık Erol (ORCID: https://orcid.org/0000-0002-7337-4973)
- Gökmen Umut Erdem
- Nilüfer Bulut (ORCID: https://orcid.org/0000-0002-2406-1946)
Institutions
- Istanbul Metropolitan Municipality (TR)
- Ümraniye Eğitim ve Araştırma Hastanesi (TR)
- University of Health Sciences Antigua (AG)
Publication Details
- Journal
- World Journal of Gastrointestinal Surgery
- Published
- 2025-05-29
- DOI
- https://doi.org/10.4240/wjgs.v17.i6.106517
- Citations
- 2
- Primary Topic
- Gastric Cancer Management and Outcomes
- Type
- article
- Field-Weighted Citation Impact
- 3.04